medline.ch Gynäkologie Mammae

	Is rechallenge with CDK4/6 inhibitors beyond progression reasonable for patients with hormone receptor-positive and HER2-negative advanced breast cancer?-a commentary on the PALMIRA trial. Chin Clin Oncol Shimura M, Mukohara T. PMID: 42145011 [PubMed - in process]
	First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results. Chin Clin Oncol Takahashi Y, Nakamoto S, Tanioka M, Shien T. PMID: 42145006 [PubMed - in process]
	Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS. Breast J Huang C, Parmar P, Habboosh N, Bhimani F, Chen Y, Entenberg D, Oktay M, Gupta A, Pastoriza J, McEvoy M, Feldman S. PMID: 42144978 [PubMed - indexed for MEDLINE]
	Patient Out-of-Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims-Based Study. J Surg Oncol Proussaloglou EM, Ren Y, Fayanju OM, Blitzblau RC, Berger ER, Valero M, Shelley Hwang E, Wheeler SB, Greenup RA. PMID: 42144808 [PubMed - as supplied by publisher]
	Effect of obesity and endocrine therapy on the prognosis of premenopausal women with HR+HER2-breast cancer: a multi-center retrospective study. Sci Rep Lian W, Hong C, Wang C, Chen D. PMID: 42144406 [PubMed - indexed for MEDLINE]
	Emerging trends in implication of nanocarriers in repolarization of tumor associated macrophages for improved triple negative breast cancer therapy. Colloids Surf B Biointerfaces Banjare N, Singh M, Kuiry A, Gupta PN. PMID: 42143910 [PubMed - as supplied by publisher]
	Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study. J Inorg Biochem Helal MA, Abdel-Mohsen MA, Toson EA. PMID: 42143555 [PubMed - as supplied by publisher]
	Latent profiles of parenting concerns and influencing factors among Chinese breast cancer mothers: a mixed-methods study. Eur J Oncol Nurs Zhang YH, Xu Q, Cao ZY, Ding M, Wang ZZ, Hong JF. PMID: 42143437 [PubMed - as supplied by publisher]
	Predictors of pathologic complete response in tripleâ€‘negative breast cancer treated with neoadjuvant chemotherapy: a systematic review and meta-analysis. Clin Exp Med Li X, Peng K, Li Q. PMID: 42143190 [PubMed - as supplied by publisher]
	Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model. Sci Rep Keshavarz F, Kouchaki A, Soltanshahi M, Jaafari MR, Mafi AR, Shabani M, Jalali SA. PMID: 42143109 [PubMed - as supplied by publisher]
	Betulinic acid is associated with miR-21 modulation, apoptosis and redox changes in breast cancer cells: an in vitro and in silico study. Sci Rep Mahmoud MA, Abdo H, Mekky M, Salem T, Mabrouk S, Khaled B. PMID: 42143107 [PubMed - indexed for MEDLINE]
	Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions. Cancer Lett Sabit H, Ghazy A, Albogami KFKM, Abdelhadi OE, Abdel-Ghany S, Arneth B. PMID: 42142702 [PubMed - as supplied by publisher]
	Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial. Radiother Oncol Shaitelman SF, Krishnamurthy S, Lin H, Rauch GM, Shen Y, Valero V, Johnson HM, Muruganandham M, Smith BD, Hoffman KE, Lee BM, Shinn E, Symmans WF, Woodward WA, Mitchell MP, Goodman CR, Buzdar A, Singh P, Tamirisa N, Kuerer H, Division of Radiation Oncology Biomarker Strategic Initiative Laboratory Group, Exceptional Responders Study Group. PMID: 42142534 [PubMed - as supplied by publisher]
	"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?". Eur J Cancer Conforti F, Sala I, Pala L, Bendoni M, Canzian J, Tinterri B, De Pas T, Locatelli M, Bagnardi V, Gelber R. PMID: 42142430 [PubMed - as supplied by publisher]
	An exploratory study on exposure to bisphenol A analogues and breast cancer risk. Environ Int Siddique S, Habibagahi A, Marro L, Bouraoui I, Kubwabo C, Harris SA. PMID: 42142421 [PubMed - as supplied by publisher]
	Increasing efficiency in the ACR Digital Mammography QC Manual's DBT Z-resolution evaluation. J Appl Clin Med Phys Fisher RF, Bevins NB, Hulme KW, Schaeffer C. PMID: 42142398 [PubMed - indexed for MEDLINE]
	Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial. Br J Surg Ishitobi M, Tanaka K, Shimomura A, Yamanaka T, Tsukioki T, Iwata H, Hara F, Fujisawa T, Sasaki K, Kajikawa R, Sakai T, Sagara Y, Shigematsu H, Ozaki Y, Nozawa K, Sudo K, Naito Y, Terata K, Ishiba T, Fukuda H, Shien T. PMID: 42142363 [PubMed - as supplied by publisher]
	Meta-analytic estimates of Risk of Malignancy (ROM) of cytopathology reporting systems: Lacunae, limitations and a proposed solution with an example from the IAC Yokohama system for breast cytopathology. Acta Cytol Jandrasupalli KK, Singh M, Singh N, Rajaganesh S, Chowdhury N. PMID: 42142344 [PubMed - as supplied by publisher]
	Association of CA12 with calcification in ER+/HER-2 negative breast cancer. Discov Oncol Zhu Y, Du Q, Ma Y, Xu N, Luo Y, Liu D. PMID: 42142233 [PubMed - as supplied by publisher]
	Effects of yoga on depressive symptoms in breast cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer Li Y, Wang J, Wang Z, Yun J, Yang Y, Yang X, Xiao X, Ren C. PMID: 42142147 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 217714

Seite 1 von 10886

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung